Follow up study adaptive servoventilation in HFREF

• Conditions: G47.3; Sleep apnoea

• Registration Number: DRKS00011524
• Lead Sponsor: Fachkrankenhaus Kloster Grafschaft GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-05-26
• Study Start: 2017-01-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

Therapy by a ventilator with adaptive servoventilation mode

Exclusion Criteria

Age <18 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- therapy quality: by comparison to published normal values of quantitative sleep Parameters and sleep disordered breathing as well as by comparison to the native measurement a decision could be made whether the established ASV therapy or the APAP therapy provides a better therapy quality (polysomographic investigation)<br><br>- patient decision: after explaining the risk factors for ASV usage as published in the SERVE-HF study and explaining the results of our investigations to the patient the patient could decide between three possibilities for future treatment: discontinuation of the therapy, Switch to the alternative APAP therapy, go on with the established ASV therapy

Secondary Outcome Measures

Name	Time	Method
- sleep quality: by comparison to published normal values of quantitative sleep parameters sleep quality in the individual patient can be determined<br><br>- number/proportion of therapy discontinuation: patients who decide for discontinuation of therapy at all (ASV as well as APAP)